Ey. Kim et al., Attenuation of Zn2+ neurotoxicity by aspirin: Role of N-type Ca2+ channel and the carboxyl acid group, NEUROBIOL D, 8(5), 2001, pp. 774-783
Synaptically released Zn2+ ions enter into neurons primarily through voltag
e-gated Ca2+ channels (VGCC) or N-methyl-D-aspartate (NMDA) receptors, whic
h can mediate pathological neuronal death. We studied the possibility (and
underlying mechanisms) that aspirin, known to prevent NMDA neurotoxicity, w
ould also attenuate Zn2+ neurotoxicity. Administration of 3 to 10 mM aspiri
n, in cortical cell cultures, attenuated the evolution of neuronal death fo
llowing exposure to 300 muM Zn2+ for 30 min. This neuroprotective effect of
aspirin was attributable to the prevention of Zn2+ ion entry. Aspirin inte
rfered with inward currents and an increase in [Ca2+](i) through VGCC and s
elective binding of omega -conotoxin, sensitive to N-type Ca2+ channel. The
omega -conotoxins GVIA or MVIIC, the selective inhibitors of N-type Ca2+ c
hannels, attenuated Zn-2+ neurotoxicity. Aspirin derivatives lacking the ca
rboxyl acid group did not reduce Zn2+ neurotoxicity. The present findings s
uggest that aspirin prevents Zn2+-mediated neuronal death by interfering wi
th VGCC, and its action specifically requires the carboxyl acid group. (C)
2001 Academic Press.